ArticleJournal of managed care & specialty pharmacy2021

Short-term cost-effectiveness of oral semaglutide for the treatment of type 2 diabetes mellitus in the United States.

Jiayu Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.